CCM
IDXX icon

Catapult Capital Management’s Idexx Laboratories IDXX Stock Holding History

Catapult Capital Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-75,000
Closed -$4.81M – 183
2015
Q2 		$4.81M Buy
+75,000
New +$5.19M 0.69% 37
2015
Q1 		– Sell
-15,000
Closed -$1.11M – 232
2014
Q4 		$1.11M Buy
+15,000
New +$1.05M 0.28% 105

Other funds holding IDXX

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Catapult Capital Management's IDXX Position: Q3 2015 in Review

Catapult Capital Management sold out of Idexx Laboratories (IDXX) in Q3 2015, closing a stake of 75,000 shares — an estimated $4.81M sold.

Catapult Capital Management first reported a position in IDXX in Q4 2014 and held it in 2 quarters. The position peaked at $4.81M in Q2 2015. 357 funds tracked by Wall St. Rank hold IDXX as of Q3 2015.

  • Catapult Capital Management reported no remaining Idexx Laboratories position as of Q3 2015 after selling out during the quarter.
  • Catapult Capital Management sold 75,000 Idexx Laboratories shares in Q3 2015, an estimated $4.81M.
  • Catapult Capital Management first reported a position in Idexx Laboratories in Q4 2014 and held it in 2 quarters.
  • Catapult Capital Management's Idexx Laboratories position peaked at $4.81M in Q2 2015.
  • 357 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2015.

Based on Catapult Capital Management's 13F filing for Q3 2015, filed 16 Nov 2015.